From the Department of Radiology (A.T.), University of Southern California, Los Angeles, California
the Mallinckrodt Institute of Radiology (T.J.H., R.O.C., J.W.J.), St. Louis, Missouri.
AJNR Am J Neuroradiol. 2018 Sep;39(9):1768-1773. doi: 10.3174/ajnr.A5752. Epub 2018 Aug 9.
Percutaneous radiofrequency ablation combined with vertebral augmentation has emerged as a minimally invasive treatment for patients with vertebral metastases who do not respond to or have contraindications to radiation therapy. The prevalence of posterior vertebral body metastases presents access and treatment challenges in the unique anatomy of the spine. The purpose of this study was to evaluate the safety and efficacy of simultaneous bipedicular radiofrequency ablation using articulating bipolar electrodes combined with vertebral augmentation for local tumor control of spinal metastases.
Imaging-guided simultaneous bipedicular radiofrequency ablation combined with vertebral augmentation was performed in 27 patients (33 tumors) with vertebral metastases selected following multidisciplinary consultations, to achieve local tumor control in this retrospective study. Tumor characteristics, procedural details, and complications were documented. Pre- and postprocedural cross-sectional imaging was evaluated to assess local tumor control rates.
Thirty-three tumors were successfully ablated in 27 patients. Posterior vertebral body or pedicle involvement or both were present in 94% (31/33) of cases. Sixty-seven percent (22/33) of the tumors involved ≥75% of the vertebral body volume. Posttreatment imaging was available for 79% (26/33) of the treated tumors. Local tumor control was achieved in 96% (25/26) of tumors median imaging follow up of 16 weeks. No complications were reported, and no patients had clinical evidence of metastatic spinal cord compression at the treated levels.
Simultaneous bipedicular radiofrequency ablation combined with vertebral augmentation is safe and effective for local tumor control of vertebral metastases. Articulating bipolar electrodes enable the placement and proximity necessary for optimal confluence of the ablation zones. Local tumor control may lead to more durable pain palliation, prevent disease progression, and reduce skeletal-related events of the spine.
经皮射频消融联合椎体强化术已成为一种微创治疗方法,适用于对放射治疗无反应或存在禁忌证的椎体转移患者。后柱椎体转移瘤的发病率较高,给脊柱的独特解剖结构带来了治疗上的挑战。本研究旨在评估使用关节双极电极进行双侧经皮射频消融联合椎体强化术治疗脊柱转移瘤的安全性和疗效,以实现局部肿瘤控制。
在多学科会诊后,选择 27 例(33 个肿瘤)椎体转移瘤患者进行影像学引导下的双侧经皮射频消融联合椎体强化术,以实现局部肿瘤控制。记录肿瘤特征、手术细节和并发症。术前和术后的横断面影像学检查评估局部肿瘤控制率。
27 例患者的 33 个肿瘤均成功消融。94%(31/33)的病例存在后柱椎体或椎弓根受累或两者均受累。67%(22/33)的肿瘤累及≥75%的椎体体积。26/33 例(79%)的治疗肿瘤有术后影像学资料。26 例肿瘤中有 25 例(96%)在 16 周的中位影像学随访中达到了局部肿瘤控制。无并发症发生,在治疗水平也没有患者出现转移性脊髓压迫的临床证据。
双侧经皮射频消融联合椎体强化术治疗椎体转移瘤安全有效,可实现局部肿瘤控制。关节双极电极可实现消融区域的最佳融合所需的放置和接近。局部肿瘤控制可能会带来更持久的疼痛缓解,防止疾病进展,并减少脊柱相关事件的发生。